No Data
No Data
Jefferies Maintains Sangamo Therapeutics(SGMO.US) With Buy Rating, Maintains Target Price $3
Express News | HC Wainwright & Co. Reiterates Buy on Sangamo Therapeutics, Maintains $10 Price Target
Wells Fargo Maintains Sangamo Therapeutics(SGMO.US) With Hold Rating, Cuts Target Price to $2
Sangamo Therapeutics Stock Plummets 56% After Pfizer Ends Hemophilia Treatment Partnership -- Barrons.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
US Equities Markets End Lower Tuesday In Last Trading Session of 2024
mash00 : Today is the day